Meta-analysis of the efficacy of escitalopram and citalopram in the treatment of major depressive disorder.

被引：0
|
作者：
Kasper, S
Auquier, P
Robitail, S
Llorca, PM
Rive, B
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Fac Med, Marseille, France
[3] Ctr Hosp Univ, Clermont Ferrand, France
来源：
NORDIC JOURNAL OF PSYCHIATRY | 2005年 / 59卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：413 / 413
页数：1
相关论文
共 50 条
  • [21] Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder
    Azorin, JM
    Llorca, PM
    Despiegel, N
    Verpillat, P
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2004, 30 (02): : 158 - 166
  • [22] Escitalopram versus duloxetine in acute treatment of major depressive disorder: a meta-analysis and systematic review
    Maneeton, B.
    Maneeton, N.
    Woottiluk, P.
    Likhitsathian, S.
    Boonyanaruthee, V.
    Srisurapanont, M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S859 - S860
  • [23] Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis
    Kennedy, SH
    Andersen, HF
    Lam, RW
    [J]. JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2006, 31 (02): : 122 - 131
  • [24] Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis
    Na, Kyoung-Sae
    Lee, Kang Joon
    Lee, Ji Sung
    Cho, Young Sung
    Jung, Han-Yong
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2014, 48 : 79 - 85
  • [25] Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-Analysis
    Papakostas, George, I
    Salloum, Naji C.
    Hock, Rebecca S.
    Jha, Manish K.
    Murrough, James W.
    Mathew, Sanjay J.
    Iosifescu, Dan, V
    Fava, Maurizio
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (04)
  • [26] Efficacy of agomelatine in major depressive disorder: meta-analysis and appraisal
    Singh, Surendra P.
    Singh, Vidhi
    Kar, Nilamadhab
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (03): : 417 - 428
  • [27] Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram, in patients with major depressive disorder - The Navigade Switch study
    Schmitt, L
    Arbus, C
    Tonnoir, B
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2006, 32 (02): : 270 - 277
  • [28] Increase of 5-HTT occupancy during escitalopram or citalopram treatment correlates with antidepressant efficacy in major depressive disorder
    Akimova, E.
    Savli, M.
    Haeusler, D.
    Fink, M.
    Hahn, A.
    Wadsak, W.
    Mitterhauser, M.
    Lanzenberger, R.
    Kletter, K.
    Kasper, S.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S424 - S425
  • [29] Are equivalent doses of escitalopram and citalopram equally effective in major depressive disorder?
    Wade, A
    Lepola, U
    Andersen, HF
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S349 - S350
  • [30] Comparative efficacy of escitalopram and duloxetine in the acute treatment of major depressive disorder
    Bose, A.
    Gommoll, C.
    Li, D.
    Gandhi, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S349 - S350
12345